BACKGROUND: The objective of this study was to assess current perceptions surrounding opioid prescribing in surgical oncology to inform perioperative quality improvement initiatives. METHODS: After the Society of Surgical Oncology (SSO) approval, a survey was distributed to its membership. Five sample procedures were used to assess provider perceptions and prescribing habits. Data were summarized and compared by self-reported demographics. RESULTS: One hundred and seventy-five participants completed the survey: 149 (85%) faculty, 24 (14%) trainees, and 2 (1%) advanced practice providers. Most participants (76%) practiced in academic programs and 21% practiced in non-US locations. Few differences were identified based on clinical role, academic rank, or practice years. Compared with non-US providers, US providers expected higher pain scores at discharge, recommended greater opioid prescriptions, and estimated more days of opioid use for almost every procedure. More non-US providers believed discharge opioids should not be distributed to patients who are opioid-free in their last 24 inpatient hours (80% vs 50%, P = .001). All providers ranked education as "very important" for reducing opioid prescriptions. CONCLUSIONS: Compared with their international counterparts, US surgical oncology providers expected greater opioid needs and recommended higher prescription numbers. Educating providers on multimodal opioid-sparing bundles, accelerated weaning protocols, and standardized discharge prescribing habits could have a positive impact the US opioid epidemic.
BACKGROUND: The objective of this study was to assess current perceptions surrounding opioid prescribing in surgical oncology to inform perioperative quality improvement initiatives. METHODS: After the Society of Surgical Oncology (SSO) approval, a survey was distributed to its membership. Five sample procedures were used to assess provider perceptions and prescribing habits. Data were summarized and compared by self-reported demographics. RESULTS: One hundred and seventy-five participants completed the survey: 149 (85%) faculty, 24 (14%) trainees, and 2 (1%) advanced practice providers. Most participants (76%) practiced in academic programs and 21% practiced in non-US locations. Few differences were identified based on clinical role, academic rank, or practice years. Compared with non-US providers, US providers expected higher pain scores at discharge, recommended greater opioid prescriptions, and estimated more days of opioid use for almost every procedure. More non-US providers believed discharge opioids should not be distributed to patients who are opioid-free in their last 24 inpatient hours (80% vs 50%, P = .001). All providers ranked education as "very important" for reducing opioid prescriptions. CONCLUSIONS: Compared with their international counterparts, US surgical oncology providers expected greater opioid needs and recommended higher prescription numbers. Educating providers on multimodal opioid-sparing bundles, accelerated weaning protocols, and standardized discharge prescribing habits could have a positive impact the US opioid epidemic.
Authors: Timothy E Newhook; Timothy J Vreeland; Whitney L Dewhurst; Xuemei Wang; Laura Prakash; Chun Feng; Morgan L Bruno; Michael P Kim; Thomas A Aloia; Jean-Nicolas Vauthey; Jeffrey E Lee; Matthew H G Katz; Ching-Wei D Tzeng Journal: Ann Surg Date: 2020-07 Impact factor: 12.969
Authors: Kahina Abdesselam; Matthew James Dann; Ramona Alwis; Julie Laroche; Samuel Ileka-Priouzeau Journal: Health Promot Chronic Dis Prev Can Date: 2018-09 Impact factor: 3.240
Authors: Maureen V Hill; Ryland S Stucke; Sarah E Billmeier; Julia L Kelly; Richard J Barth Journal: J Am Coll Surg Date: 2017-11-30 Impact factor: 6.113
Authors: Natasa Gisev; Sallie-Anne Pearson; Timothy Dobbins; David C Currow; Fiona Blyth; Sarah Larney; Adrian Dunlop; Richard P Mattick; Andrew Wilson; Louisa Degenhardt Journal: BMJ Open Date: 2018-12-04 Impact factor: 2.692
Authors: Karim S Ladha; Mark D Neuman; Gabriella Broms; Jennifer Bethell; Brian T Bateman; Duminda N Wijeysundera; Max Bell; Linn Hallqvist; Tobias Svensson; Craig W Newcomb; Colleen M Brensinger; Lakisha J Gaskins; Hannah Wunsch Journal: JAMA Netw Open Date: 2019-09-04
Authors: Yuki Hirata; Russell G Witt; Laura R Prakash; Elsa M Arvide; Kristen A Robinson; Vijaya Gottumukkala; Ching-Wei D Tzeng; Paul Mansfield; Brian D Badgwell; Naruhiko Ikoma Journal: Ann Surg Oncol Date: 2022-05-04 Impact factor: 4.339
Authors: Russell G Witt; Timothy E Newhook; Laura R Prakash; Morgan L Bruno; Elsa M Arvide; Whitney L Dewhurst; Naruhiko Ikoma; Jessica E Maxwell; Michael P Kim; Jeffrey E Lee; Matthew H G Katz; Ching-Wei D Tzeng Journal: J Surg Res Date: 2022-03-17 Impact factor: 2.417
Authors: Russell G Witt; Brandon Cope; Yi-Ju Chiang; Timothy Newhook; Heather Lillemoe; Ching-Wei D Tzeng; Iris B Chen; Sarah B Fisher; Anthony Lucci; Jennifer A Wargo; Jeffrey E Lee; Merrick I Ross; Jeffrey E Gershenwald; Justine Robinson; Emily Z Keung Journal: J Surg Oncol Date: 2021-12-14 Impact factor: 2.885
Authors: Bradford J Kim; Timothy E Newhook; Alisa Blumenthaler; Yi-Ju Chiang; Thomas A Aloia; Christina L Roland; Matthew H G Katz; Jean-Nicolas Vauthey; Jeffrey E Lee; Ching-Wei D Tzeng Journal: J Surg Oncol Date: 2021-03-22 Impact factor: 2.885